statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Futures Rebound From Thursday Rout Ahead Of Core PCE

Futures Rebound From Thursday Rout Ahead Of Core PCE

 One day after closing at the lowest level in more than a month, US equity futures have rebounded led by small-caps with tech names...

Why Is Omnipod Insulin Device Maker Insulet Stock Jumping Today?

Insulet Corporation shares are rising after the company reported stronger-than-expected second-quarter revenue, driven by high demand for Omnipod 5 and a raised full-year revenue outlook.
read more...

Insulet Reports Preliminary Second Quarter 2024 Revenue Results

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod brand of products, today announced certain preliminary revenue...

A Closer Look at 7 Analyst Recommendations For Insulet

Latest Ratings for PODD
 DateFirmActionFromTo Feb 2022Morgan StanleyMaintainsEqual-Weight Feb 2022Raymond JamesMaintainsOutperform Feb 2022Piper SandlerMaintainsNeutral
 View More Analyst...

CereVasc Announces Appointments of New Directors

CereVasc Announces Appointments of New Directors CereVasc Announces Appointments of New Directors PR Newswire BOSTON, July 16, 2024 Medical Device LeadersShlomi Nachman and Timothy Scannell to join...

Insulet to Announce Second Quarter 2024 Financial Results on August 8, 2024

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod brand of products, today announced plans to release its financial...

Insulets SECURE-T2D Pivotal Trial Results Demonstrate Omnipod 5 Improves Clinical Outcomes and Quality of Life in Type 2 Diabetes

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod brand of products, today shared positive results from its Omnipod 5...

Insulet Announces Full Commercial Launch of Omnipod 5 with Expanded Sensor Integrations in the United Kingdom and the Netherlands

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod brand of products, today announced that Omnipod 5, compatible with...

Insulet Announces Omnipod 5 Launch in France and U.S. Innovation Updates

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod brand of products, today made several exciting announcements...

Looking Into Insulet's Recent Short Interest

Insulet Corp. is a medical device company, which engages in the development, manufacture, and marketing of an insulin infusion system for people with insulin-dependent diabetes. It specializes in diabetes supplies, including the OmniPod System, as well as other diabetes related products and supplies such as blood glucose testing supplies, traditional insulin pumps, pump supplies, and pharmaceuticals. The company was founded by John L. Brooks III and John T. Garibotto in July 2000 and is headquartered in Acton, MA.

Volume	1.85M
52-Wk High	$281.83
52-Wk Low	$125.82

PODD Insulet Corporation

About

Feed

News

Sentiment

Earnings

Fundamentals